Curcumin-loaded mesoporous silica nanoparticles (MSNs) have shown promise as drug
delivery systems to address the limited pharmacokinetic characteristics of curcumin …

Cancer therapies have advanced tremendously throughout the last decade, yet multiple
factors still hinder the success of the different cancer therapeutics. The traditional therapeutic …

The enormous versatility of mesoporous silica nanoparticles permits the creation of a large
number of nanotherapeutic systems for the treatment of cancer and many other pathologies …

Mesoporous silica nanocarrier (MSN) preparations have a wide range of medical
applications. Studying the biocompatibility of MSN is an important part of clinical …

Mesoporous silica nanoparticles have attracted much attention in recent years as drug and
gene delivery systems for biomedical applications. Among their most beneficial features for …

Injectable in situ forming hydrogels are amongst the efficient local drug delivery systems for
cancer therapy. Providing a 3D hydrogel network within the target tissue capable of …

Over the last 30 years, genetically engineered DNA has been tested as novel vaccination
strategy against various diseases, including human immunodeficiency virus (HIV), hepatitis …

Advances in gene therapy have been foreshadowing its potential for the treatment of a vast
range of diseases involving genetic malfunctioning. However, its therapeutic efficiency and …

The mesoporous silica nanoparticles (MSNs), because of the synthesis, ease of surface
functionalization, tunable pore size, large surface area, and biocompatibility, are being …

Cellular delivery of DNA using silica nanoparticles has attracted great attention. Typically,
polyethyleneimine (PEI) is used to form a silica/PEI composite vector. Understanding the …